China's Leading CRO, Wuxi PharmaTech, Sees Relatively Smooth Sailing Ahead Following Tempest-marked Odyssey Of Global Crisis

BEIJING - As the globe's pharmaceutical giants moved more research operations to lower cost China, the country's leading contract research organization, Wuxi PharmaTech, posted a strong rebound in 2009 earnings after recording a massive loss the previous year